Home2025-02-28T09:10:04+11:00

MIA’s CO-MEDICAL DIRECTORS
2024 AUSTRALIANS OF THE YEAR

australians-of-the-year

WORLD-FIRST EXPERIMENTAL CANCER TREATMENT PAVES WAY FOR CLINICAL TRIAL

Nature Medicine has published a peer reviewed paper detailing the experimental glioblastoma cancer treatment developed by Professor Georgina Long AO, Medical Director of Melanoma Institute Australia, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre in Melbourne.

Professor Long used her expertise in immunotherapy and drew on melanoma science to devise, lead and administer the treatment, the first documented use of neoadjuvant triple immunotherapy in glioblastoma.

NATIONAL PRESS CLUB

Our Co-Medical Directors delivered their 2nd address to the National Press Club, this time detailing world-first breakthroughs in applying melanoma science to Prof Scolyer’s brain cancer.

LATEST NEWS

MIA’s MISSION
ZERO DEATHS FROM MELANOMA

MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.

MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.

STATE OF THE NATION
REPORT INTO MELANOMA

A roadmap to how we can achieve zero deaths from melanoma by 2030.

1300

It is estimated 1300 Australians will die from melanoma this year

30 mins

1 Australian is diagnosed with melanoma every 30 minutes

90%

If caught early 90% of melanomas can be cured by surgery

Age 20-39

Melanoma is the most common cancer affecting Australians aged 20 to 39

PATIENT GUIDES
FOR EVERY STAGE
OF MELANOMA

(including prevention)

STAY SUN-SAFE
ALL YEAR ROUND

Go to Top